A Structured Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital
About this trial
This randomized clinical trial is evaluating the impact of a structured peer support intervention (STEPP) on psychological distress and quality of life among patients undergoing hematopoietic stem cell transplantation.
Eligibility criteria
Qualifiers
Adult patients (aged 18 years and older) with hematologic malignancies, scheduled to undergo autologous or allogeneic HSCT
Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
Disqualifiers
Patients undergoing HSCT for benign hematologic conditions
Patients with acute or unstable psychiatric or cognitive conditions (e.g., dementia) which the treating clinicians believe prohibits informed consent or compliance with study procedures
Patients undergoing HSCT for the second time
Trial design
Treatments tested in this trial
- STEPP
- Minimally Enhanced Usual Care Control
Treatment groups
350 Participants
are divided into 2 treatment groupsSponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
Dana-Farber Cancer Institute
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
Fred Hutchinson Cancer Center
Collaborator
Source ClinicalTrials.gov